van Dongen GA - Search Results

1

High dose rhenium-186-labeling of monoclonal antibodies for clinical application: pitfalls and solutions.

van Gog FB, Visser GW, Stroomer JW, Roos JC, Snow GB, van Dongen GA. van Gog FB, et al. Among authors: van dongen ga. Cancer. 1997 Dec 15;80(12 Suppl):2360-70. Cancer. 1997. PMID: 9406684

2

Potential for targeting head and neck squamous cell carcinoma with monoclonal antibody K984.

Schrijvers AH, Gerretsen M, van Walsum M, Braakhuis BJ, Quak JJ, Snow GB, van Dongen GA. Schrijvers AH, et al. Among authors: van walsum m, van dongen ga. Cancer Immunol Immunother. 1992;34(4):252-8. doi: 10.1007/BF01741793. Cancer Immunol Immunother. 1992. PMID: 1371426

3

Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I-labelled monoclonal antibody E48 IgG.

Gerretsen M, Schrijvers AH, van Walsum M, Braakhuis BJ, Quak JJ, Meijer CJ, Snow GB, van Dongen GA. Gerretsen M, et al. Among authors: van walsum m, van dongen ga. Br J Cancer. 1992 Sep;66(3):496-502. doi: 10.1038/bjc.1992.302. Br J Cancer. 1992. PMID: 1520586 Free PMC article.

4

Expression and characterization of two differentiation antigens in human stratified squamous epithelia and carcinomas.

Quak JJ, Schrijvers HG, Brakkee JG, Davis HD, Scheper RJ, Meijer CJ, Snow GB, Van Dongen GA. Quak JJ, et al. Among authors: van dongen ga. Int J Cancer. 1992 Feb 20;50(4):507-13. doi: 10.1002/ijc.2910500402. Int J Cancer. 1992. PMID: 1537614

5

Radioimmunoscintigraphy of head and neck cancer using 99mTc-labeled monoclonal antibody E48 F(ab')2.

van Dongen GA, Leverstein H, Roos JC, Quak JJ, van den Brekel MW, van Lingen A, Martens HJ, Castelijns JA, Visser GW, Meijer CJ, et al. van Dongen GA, et al. Among authors: van den brekel mw, van lingen a. Cancer Res. 1992 May 1;52(9):2569-74. Cancer Res. 1992. PMID: 1568225

6

Detection of squamous cell carcinoma xenografts in nude mice by radiolabeled monoclonal antibody E48.

Quak JJ, Gerretsen M, Schrijvers AH, Meijer CJ, van Dongen GA, Snow GB. Quak JJ, et al. Among authors: van dongen ga. Arch Otolaryngol Head Neck Surg. 1991 Nov;117(11):1287-91. doi: 10.1001/archotol.1991.01870230103017. Arch Otolaryngol Head Neck Surg. 1991. PMID: 1747235

7

Evidence for a role of the monoclonal antibody E48 defined antigen in cell-cell adhesion in squamous epithelia and head and neck squamous cell carcinoma.

Schrijvers AH, Gerretsen M, Fritz JM, van Walsum M, Quak JJ, Snow GB, van Dongen GA. Schrijvers AH, et al. Among authors: van walsum m, van dongen ga. Exp Cell Res. 1991 Oct;196(2):264-9. doi: 10.1016/0014-4827(91)90260-2. Exp Cell Res. 1991. PMID: 1893937

8

Preclinical in vivo activity of 2',2'-difluorodeoxycytidine (Gemcitabine) against human head and neck cancer.

Braakhuis BJ, van Dongen GA, Vermorken JB, Snow GB. Braakhuis BJ, et al. Among authors: van dongen ga. Cancer Res. 1991 Jan 1;51(1):211-4. Cancer Res. 1991. PMID: 1988086

9

Superior localisation and imaging of radiolabelled monoclonal antibody E48 F(ab')2 fragment in xenografts of human squamous cell carcinoma of the head and neck and of the vulva as compared to monoclonal antibody E48 IgG.

Gerretsen M, Quak JJ, Suh JS, van Walsum M, Meijer CJ, Snow GB, van Dongen GA. Gerretsen M, et al. Among authors: van walsum m, van dongen ga. Br J Cancer. 1991 Jan;63(1):37-44. doi: 10.1038/bjc.1991.9. Br J Cancer. 1991. PMID: 1989663 Free PMC article.

10

Comparative study of the sensitivity of head and neck cell lines to methotrexate (MTX) and the analog 10-ethyl, 10-deazaaminopterin (10-EdAM).

Brown DH, Braakhuis BJ, Van Dongen GA, Snow GB. Brown DH, et al. Among authors: van dongen ga. Otolaryngol Head Neck Surg. 1990 Jan;102(1):20-5. doi: 10.1177/019459989010200104. Otolaryngol Head Neck Surg. 1990. PMID: 2106113

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results